Sign In
Buy TRVN
$0.0010
+0 (+0%)
At Close: Jun 03, 2026
Analysts Estimate Trevena (TRVN) to Report a Decline in Earnings: What to Look Out for
04:35pm, Thursday, 28'th Apr 2022
Trevena (TRVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trevena Announces Results from Respiratory Physiology Study of Head-to-Head Comparison of OLINVYK® and IV Morphine in Elderly/Overweight Subjects
11:00am, Wednesday, 20'th Apr 2022 GlobeNewswire Inc.
OLINVYK showed a statistically significant reduced impact on respiratory function compared to IV morphine, among elderly/overweight subjects
Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ex-US Royalty-Based Financing with R-Bridge Healthcare Fund
11:00am, Monday, 18'th Apr 2022 GlobeNewswire Inc.
CHESTERBROOK, Pa., April 18, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with
OLINVYK® data selected as President’s Choice abstract at Annual Regional Anesthesiology and Acute Pain Medicine Meeting and Featured at American Burn Association Annual Meeting
08:05pm, Wednesday, 13'th Apr 2022 GlobeNewswire Inc.
CHESTERBROOK, Pa., April 13, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with
Trevena, Inc.'s (TRVN) CEO Carrie Bourdow on Q4 2021 Results - Earnings Call Transcript
05:44pm, Thursday, 31'st Mar 2022
Trevena, Inc.'s (TRVN) CEO Carrie Bourdow on Q4 2021 Results - Earnings Call Transcript
Trevena (TRVN) Reports Q4 Loss, Lags Revenue Estimates
12:15pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Trevena (TRVN) delivered earnings and revenue surprises of 11.11% and 100.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare Fund, an affiliate of CBC Group
11:02am, Thursday, 31'st Mar 2022 GlobeNewswire Inc.
CHESTERBROOK, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with
Trevena (TRVN) Reports Q4 Loss, Lags Revenue Estimates
09:47am, Thursday, 31'st Mar 2022
Trevena (TRVN) delivered earnings and revenue surprises of 11.11% and 100.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Trevena to Release Fourth Quarter and Full Year 2021 Financial Results on March 31, 2022
07:00am, Wednesday, 30'th Mar 2022
Company to host a Conference Call & Webcast at 8:00 a.m. ET Company to host a Conference Call & Webcast at 8:00 a.m. ET
AVEO Pharmaceuticals (AVEO) Reports Q4 Loss, Misses Revenue Estimates
12:15pm, Monday, 14'th Mar 2022 Zacks Investment Research
AVEO (AVEO) delivered earnings and revenue surprises of 40% and 6.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Cidara Therapeutics (CDTX) Reports Q4 Loss, Tops Revenue Estimates
11:55pm, Monday, 07'th Mar 2022 Zacks Investment Research
Cidara Therapeutics (CDTX) delivered earnings and revenue surprises of 21.21% and 84.78%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Trevena to Participate in the Upcoming January Conferences
09:05pm, Monday, 03'rd Jan 2022 GlobeNewswire Inc.
CHESTERBROOK, Pa., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with c
Stock Runner: Trevena, Inc. (NASDAQ:TRVN), The Southern Company (NYSE:SO)
04:31am, Friday, 24'th Dec 2021 Stock Equity
Trevena, Inc. (NASDAQ:TRVN) with the stream of 5.21% also noticed, India The Southern Company (NYSE:SO) encountered a rapid change of -0.17% in the last hour of Thursdays trading session. Trevena, The post Stock Runner: Trevena, Inc. (NASDAQ:TRVN), The Southern Company (NYSE:SO) appeared first on Stocks Equity .
Flaming Stock: Trevena, Inc. (NASDAQ:TRVN), Mastercard Incorporated (NYSE:MA)
12:44am, Monday, 20'th Dec 2021 Stock Equity
Trevena, Inc. (NASDAQ:TRVN) with the stream of 5.64% also noticed, India Mastercard Incorporated (NYSE:MA) encountered a rapid change of -1.02% in the last hour of Fridays trading session. Trevena, Inc. The post Flaming Stock: Trevena, Inc. (NASDAQ:TRVN), Mastercard Incorporated (NYSE:MA) appeared first on Stocks Equity .
Zacks: Analysts Anticipate Trevena, Inc. (NASDAQ:TRVN) Will Announce Quarterly Sales of $670,000.00
06:58am, Saturday, 18'th Dec 2021 Dakota Financial News
Analysts expect Trevena, Inc. (NASDAQ:TRVN) to post sales of $670,000.00 for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Trevenas earnings, with estimates ranging from $280,000.00 to $1.06 million. Trevena posted sales of $70,000.00 in the same quarter last year, which suggests a positive year-over-year growth rate of 857.1%. []
